<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://hboevidence.wikis.unsw.edu.au/index.php?action=history&amp;feed=atom&amp;title=Fedorko</id>
	<title>Fedorko - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://hboevidence.wikis.unsw.edu.au/index.php?action=history&amp;feed=atom&amp;title=Fedorko"/>
	<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;action=history"/>
	<updated>2026-10-05T08:40:12Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.31.0</generator>
	<entry>
		<id>http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;diff=861&amp;oldid=prev</id>
		<title>M.bennett at 06:39, 22 December 2020</title>
		<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;diff=861&amp;oldid=prev"/>
		<updated>2020-12-22T06:39:28Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;amp;diff=861&amp;amp;oldid=860&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>M.bennett</name></author>
		
	</entry>
	<entry>
		<id>http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;diff=860&amp;oldid=prev</id>
		<title>M.bennett at 06:39, 22 December 2020</title>
		<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;diff=860&amp;oldid=prev"/>
		<updated>2020-12-22T06:39:04Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;amp;diff=860&amp;amp;oldid=85&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>M.bennett</name></author>
		
	</entry>
	<entry>
		<id>http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;diff=85&amp;oldid=prev</id>
		<title>Gordoben: Imported from Wikispaces</title>
		<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Fedorko&amp;diff=85&amp;oldid=prev"/>
		<updated>2018-07-17T06:18:12Z</updated>

		<summary type="html">&lt;p&gt;Imported from Wikispaces&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;'''&amp;lt;span style=&amp;quot;font-size: 16pt;&amp;quot;&amp;gt;Hyperbaric oxygen therapy did not reduce indications for amputation in patients with diabetic ulcers&amp;lt;/span&amp;gt;'''&lt;br /&gt;
{| &lt;br /&gt;
| '''&amp;lt;span style=&amp;quot;font-size: 14pt;&amp;quot;&amp;gt;1. HBOT did not reduce indication for amputation, reduce wound size or improve healing.&amp;lt;/span&amp;gt;''' &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;'''Citation/s:''' &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;1.Fedorko L, Bowen JM, Jones W, Oreopoulos G, Goeree R, Hopkins RB, O’Reilly DJ. Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Care 2016; 39, 392-399.&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;2. &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 16px;&amp;quot;&amp;gt;O'Reilly D, Linden R, Fedorko L, Tarride JE, Jones WG, Bowen JM, Goeree R. A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 16px;&amp;quot;&amp;gt;Trials. 2011 Mar 7;12:69. doi: 10.1186/1745-6215-12-69.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Lead author's name and email&amp;lt;/span&amp;gt;'''&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;: ludwik.fedorko@uhn.ca&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;'''Three-part Clinical Question''': Does hyperbaric oxygen therapy reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb?&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''Search Terms''': Diabetes, ulcer, chronic wound, wound care, amputation&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''The Study''': Double-blinded concealed randomised controlled trial with intention-to-treat.&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;The Study Patients: Ulcer of the lower limb or foot present for at least 4 weeks&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Control group (N = 54; 54 analysed): Breathing air at 1.3ATA daily for 30 treatments over 6 weeks, plus standard wound care of minimum 2 dressing changes per week&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Experimental group (N = 49; 49 analysed): Breathing 100% O2 at 2.4ATA&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;'''The Evidence''':&amp;lt;/span&amp;gt;&lt;br /&gt;
{| &lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Outcome&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Time to Outcome&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Control group rate&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;HBO group rate&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Relative risk reduction&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Absolute risk reduction&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;NNT&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Adjudicated indication for major or minor amputation (ITT)&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;6 weeks&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.48&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.51&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;4%&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.01&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;111&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|^   |||||| &amp;lt;span style'''&amp;quot;display: block; text-align: right;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;95% CIs:&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;-43% to 50%&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;-0.11 to 0.13&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;NNT ''' 8 to INF; NNH ''' 9 to INF&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
{| &lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Measure&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; |||| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Control Group&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; |||| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;HBO Group&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Difference&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;95% CI&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|^   || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Mean&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;SD&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Mean&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;SD&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; ||^   ||^   &lt;br /&gt;
|-&lt;br /&gt;
| '''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Wound measurement (reduction in digital surface area at 12 weeks)&amp;lt;/span&amp;gt;''' || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;1.8&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.42&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;1.9&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.39&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;-0.10&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;-0.15 to 0.06&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
{| &lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Non-Event Outcomes&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Time to outcome/s&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Control group &amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;HBO group&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;P-value&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Wounds healed&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;12 weeks&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;12&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;10&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.823&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Comments:&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 1. Underpowered based on an estimated sample size of 118 patients. The methods used to determine sample size or expected event rates are unclear. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 2. Only 87 patients analysed as per protocol (had completed at least 27 treatments or healed before protocol end). Intention to treat analysis captured only 103 patients. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 3. There was a change in outcome assessment from examination by a vascular surgeon to assessment of clinical notes and photographs between the ethics protocol and the published paper. This method of assessment does not seem to have been validated.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 4. Very short outcomes at only 12 weeks from first treatment session.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 5. Some baseline differences between groups may have biased the outcome. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 6. No attempt to demonstrate hypoxia as is usual in patient selection for treatment.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 7. Trans-metatarsal amputation was included in the definition of ‘major amputation’ which is unusual.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 8. No clear rationale for excluding patients who had undergone revascularisation in the previous 3 months.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;'''Appraised by''': Katherine Witheridge Department of Diving and Hyperbaric Medicine Prince of Wales Hospital ; Monday, 2 July 2018&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''Email''': katherine.witheridge@health.nsw.gov.au &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''Kill or Update By''': July 2021&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:sumhorsa.gif]]&lt;br /&gt;
&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;color: #7c00ff; display: block; font-size: 26px; text-align: center;&amp;quot;&amp;gt;'''[[Non-healing wounds  |  BACK]]'''&amp;lt;/span&amp;gt;&lt;/div&gt;</summary>
		<author><name>Gordoben</name></author>
		
	</entry>
</feed>